Products and services

      Products and services

      Ropinirole Hydrochloride Tablets

      適  應  癥: This product is suitable to treat the symptoms and signs of Primary Parkinson’s disease in combination with levodopa.

      規       格:0.5mg, 3mg (by ropinirole)

      包       裝: Laminated film package, 30 tablets/carton

      有  效  期:24 months

      批準文號:0.5mg: National Medicine Standard H20130044
                        3mg: National Medicine Standard H20130045

      - A new generation of selective ergot dopamine receptor agonists;

      - It is recommended as first-line medication for early Parkinson’s treatment by the United States, European and Chinese Parkinson's guidelines.

      - Its efficacy and safety are demonstrated by over-20-year clinical medication experience abroad.

      - The incidence of dyskinesia in early Parkinson's patients is very low, and it can significantly delay the onset of dyskinesia.

      -It assists L-dopa in the treatment of patients with advanced Parkinson’s disease. It can effectively shorten the “day off phenomenon” and reduce 20% of the usage amount of L-dopa.